Select Page
FDA Grants Pre-Approval for IND for Potential HIV Cure

FDA Grants Pre-Approval for IND for Potential HIV Cure

Jun 14, 2021 | News, Regulatory

The U.S. Food and Drug Administration (FDA) has granted pre-approval for Enochian BioSciences’ Investigational New Drug (IND) application for a potential functional treatment or cure for HIV (human immunodeficiency disorder). The submission is based off of an...
Delta Variant: Likely More Than 6% of US COVID Cases

Delta Variant: Likely More Than 6% of US COVID Cases

Jun 11, 2021 | News, Regulatory

Initially detected in India in December last year, the CDC has declared that the Delta variant (B.1.617.2.) can now be found in over 60 countries. The Delta variant appears to have a relatively higher transmissible rate and continues to delay progress combatting the...
FDA Approves New Pfizer Pneumococcal Vaccine for Adults

FDA Approves New Pfizer Pneumococcal Vaccine for Adults

Jun 9, 2021 | News, Regulatory

A new pneumococcal 20-valent conjugate vaccine by Pfizer, PREVNAR 20™, has been approved for adults by the FDA in efforts to strengthen the prevention of disease and pneumonia caused by 20 Streptococcus pneumoniae (pneumococcus) serotypes. The authorized vaccine not...
First Alzheimer’s Treatment by Biogen Approved by FDA

First Alzheimer’s Treatment by Biogen Approved by FDA

Jun 7, 2021 | News, Regulatory

The U.S Food and Drug Administration (FDA) has approved Biogen’s aducanumab treatment for Alzheimer’s which aims to eliminate the sticky deposits of amyloid beta found in the brains of patients in the initial stages of the disease. In spite of controversy and...